Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Incyte Corp (INCY US)
Watchlist
60
Analysis
Health Care
•
United States
Incyte Corp is a biopharmaceutical company. The Company discovers, develops and commercializes proprietary small molecule drugs, primarily used in oncology.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Amgen Inc
•
26 Mar 2016 10:49
Navigating Risk off Transition
ChartonicsEurope is the underperform short bet but our EM outperform hit a road block as copper turned down hard (sold down long exposure on March...
Thomas Schroeder
286 Views
Share
bullish
•
Thematic (Sector/Industry)
•
22 Jan 2016 15:52
Low Odds of U.S. Drug Pricing Reforms Create Favorable Valuations
Democratic presidential candidates' potential drug policy reforms have pressured drug stocks, and ongoing political campaigns are likely to...
Morningstar, Inc.
Follow
1.5k Views
Share
bullish
•
Thematic (Sector/Industry)
•
12 Nov 2015 09:34
Healthcare Observer: As Long-Term Patent Exposure Ebbs, Innovation in Big Pharma Pipelines Support
Pipeline innovation outpacing patent losses represents a core element of the wide moat ratings for most of the Big Pharma firms. Slowing patent...
Morningstar, Inc.
Follow
317 Views
Share
bullish
•
Thematic (Sector/Industry)
•
07 Oct 2015 11:15
Morningstar Healthcare Observer: Biotech Industry Undervalued
The median price/fair value in our biotech universe is 0.87, and in late September valuations fell to their cheapest levels since 2011. While this...
Morningstar, Inc.
Follow
285 Views
Share
bullish
•
Thematic (Sector/Industry)
•
06 Oct 2015 11:03
SoulCycle IPO - Good for your portfolio and your soul?
"Dance party on a bike" - that's how the founders of SoulCycle like to describe their business. SoulCycle is a lifestyle and fitness brand that...
Ishita Jain
251 Views
Share
First
Previous
8
9
10
11
12
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x